Table 1.
Study population characteristics (n=312)
| n* | %† | |
| Sex | ||
| Female | 128 | 41.1 |
| Male | 184 | 58.9 |
| Age | ||
| Mean (SD) | 65.2 (13.8) | |
| 18–49 | 47 | 15.0 |
| 50–64 | 97 | 31.1 |
| 65–79 | 106 | 34.1 |
| >79 | 62 | 19.7 |
| Site | ||
| Marseille | 248 | 79.7 |
| Nice | 64 | 20.3 |
| Period | ||
| 2020 | 112 | 35.8 |
| 2021 | 200 | 64.2 |
| Education | ||
| <General certificate of secondary education | 49 | 15.6 |
| General certificate of secondary education | 59 | 18.9 |
| High school diploma | 52 | 16.7 |
| ≥Diploma of higher education | 152 | 48.7 |
| Number of comorbidities/medical history | ||
| None | 97 | 31.1 |
| One | 85 | 27.3 |
| Two | 44 | 14.2 |
| Three | 42 | 13.4 |
| More than three | 44 | 14.0 |
| Daily smoker | 10 | 3.2 |
| Obesity (body mass index≥30 kg/m²) | 80 | 25.6 |
| Live alone | 77 | 24.6 |
| Works/has worked as a healthcare worker | 63 | 20.1 |
| Knows someone in his/her close circle who is a healthcare worker | 164 | 52.6 |
| Time from symptom onset to hospitalisation (days)—mean(SD) | 6.7 (3.6) | |
| Clinical outcomes | ||
| Length of hospital stay (days) (nmiss=1) | ||
| Mean (SD) | 10.8 (12.8) | |
| Transfer to intensive care unit | 158 | 50.6 |
| Follow-up/rehabilitation care after hospitalisation | 164 | 52.6 |
| Home oxygen treatment after hospitalisation | 176 | 56.6 |
| Still has sequelae of COVID-19 at the time of the survey | 153 | 49.1 |
| Physical sequelae | 126 | 40.6 |
| Neurological sequelae | 96 | 30.8 |
| Psychological sequelae | 57 | 18.2 |
| Sleep disorders sequelae | 51 | 16.5 |
*Weighted frequency otherwise stated; the sum may not add to 312 due to rounding.
†Weighted column percentages otherwise stated; the sum may not add to 100% due to rounding.